December 15, 2014

Google Logo Add Us On GoogleAdd SciAm

Farewell to “Molecules to Medicine” on SciAm

As has been announced earlier today, Scientific American blogs is "being reorganized." As part of that euphemism, many blogs, mine included, are being eliminated as of today, along with changes in their editorial policies.

By Judy Stone

Join Our Community of Science Lovers!

This article was published in Scientific American’s former blog network and reflects the views of the author, not necessarily those of Scientific American

As has been announced earlier today, Scientific American blogs is “being reorganized.” As part of that euphemism, many blogs, mine included, are being eliminated as of today, along with changes in their editorial policies.

Writing for SciAm has been a very gratifying experience. I want to especially thank Bora Zivokvic for giving me my start, inviting me to join SciAm in 2011, and to Karyn Traphagen and the folks at ScienceOnline. As I reflect all the wonderful folks I’ve met as a result, I realize how my world has been enriched through their tireless efforts, and want to thank them again.

I might occasionally appear with a guest blog post for SciAm, but my new home will be at Forbes. I appreciate their warm welcome as a Pharma and Healthcare contributor. Devotees can follow me there at Forbes and at Twitter, @drjudystone, and can contact me through either site.

On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.

Thanks, too, to the SciAm editors for having allowed me to post on topics that I was passionate about, including the problems of rural hospitals and research ethics and, in particular, having supported my series on the ethical lapses in psychiatric trials at the University of Minnesota, aka the Markingson case.

With thanks for these years at SciAm and to my ardent followers… hasta mañana.

Judy Stone, MD is an infectious disease specialist, experienced in conducting clinical research. She is the author of Conducting Clinical Research, the essential guide to the topic. She survived 25 years in solo practice in rural Cumberland, Maryland, and is now broadening her horizons. She particularly loves writing about ethical issues, and tilting at windmills in her advocacy for social justice. As part of her overall desire to save the world when she grows up, she has become especially interested in neglected tropical diseases. When not slaving over hot patients, she can be found playing with photography, friends' dogs, or in her garden. Follow on Twitter @drjudystone or on her website.

More by Judy Stone

Subscribe to Support Independent Journalism

Great science journalism requires human expertise, time, effort and creativity. And it costs money. That’s why I and the journalists here at Scientific American hope you’ll join our community.

When you subscribe, you are supporting staff and freelance journalists who are passionate about telling science stories that are true, important and compelling. Our editors and reporters are often experts in their fields, which means they understand the nuances of big discoveries and can untangle the breakthroughs from the hype. With a subscription, you are also supporting rigorous fact-checking to ensure the words we publish are precise and accurate. And you’re supporting original illustrations, graphics and photos that bring you closer to an advanced laboratory, an ice sheet in Antarctica or a space mission in orbit. You’re helping us craft other types of high-quality journalism as well: Our newsletters are carefully written, edited and curated by staffers you have or will come to know and love. Our Science Quickly podcast is based on original reporting, collaboration with editors and scientists and exacting production.

Subscriptions keep this engine running so we can continue to deliver thoughtful, rigorous and independent science journalism to you. In an era of viral misinformation, this work is crucial. If you value what we do, I hope you’ll consider joining us as a subscriber

Thank you,

Jeanna Bryner, Editor in Chief, Scientific American

Subscribe